Efficacy and Safety of Adjunctive Recombinant Human Interleukin-2 for Patients with Pulmonary Tuberculosis: A Meta-Analysis

Figure 6

Forest plots for the meta-analysis of the influence of rhuIL-2 on the incidence of adverse events; (a), fever; (b), musculoskeletal pain; (c), hepatic injury; and (d), renal toxicity.

(a)

(b)

(c)

(d)